These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1067 related items for PubMed ID: 9347202
1. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women. Lewis MA, Heinemann LA, Spitzer WO, MacRae KD, Bruppacher R. Contraception; 1997 Sep; 56(3):129-40. PubMed ID: 9347202 [Abstract] [Full Text] [Related]
2. First-time use of newer oral contraceptives and the risk of venous thromboembolism. Suissa S, Blais L, Spitzer WO, Cusson J, Lewis M, Heinemann L. Contraception; 1997 Sep; 56(3):141-6. PubMed ID: 9347203 [Abstract] [Full Text] [Related]
3. Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR. Lancet; 1997 Jan 11; 349(9045):83-8. PubMed ID: 8996419 [Abstract] [Full Text] [Related]
6. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women. Heinemann LA, Lewis MA, Thorogood M, Spitzer WO, Guggenmoos-Holzmann I, Bruppacher R. BMJ; 1997 Dec 06; 315(7121):1502-4. PubMed ID: 9420491 [Abstract] [Full Text] [Related]
9. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Lancet; 1995 Dec 16; 346(8990):1589-93. PubMed ID: 7500750 [Abstract] [Full Text] [Related]
10. Smoking and use of oral contraceptives: impact on thrombotic diseases. Lidegaard O. Am J Obstet Gynecol; 1999 Jun 16; 180(6 Pt 2):S357-63. PubMed ID: 10368521 [Abstract] [Full Text] [Related]
11. Effect of oral contraceptive progestins on serum copper concentration. Berg G, Kohlmeier L, Brenner H. Eur J Clin Nutr; 1998 Oct 16; 52(10):711-5. PubMed ID: 9805216 [Abstract] [Full Text] [Related]
12. The risks of venous thromboembolic disease among German women using oral contraceptives: a database study. Farmer RD, Todd JC, Lewis MA, MacRae KD, Williams TJ. Contraception; 1998 Feb 16; 57(2):67-70. PubMed ID: 9589831 [Abstract] [Full Text] [Related]
16. The differential risk of oral contraceptives: the impact of full exposure history. Lewis MA, MacRae KD, Kühl-Habichl D, Bruppacher R, Heinemann LA, Spitzer WO. Hum Reprod; 1999 Jun 16; 14(6):1493-9. PubMed ID: 10359554 [Abstract] [Full Text] [Related]
17. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease. Godsland IF, Crook D, Devenport M, Wynn V. Contraception; 1995 Sep 16; 52(3):143-9. PubMed ID: 7587185 [Abstract] [Full Text] [Related]
20. Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. Lewis MA, Spitzer WO, Heinemann LA, MacRae KD, Bruppacher R, Thorogood M. BMJ; 1996 Jan 13; 312(7023):88-90. PubMed ID: 8555936 [Abstract] [Full Text] [Related] Page: [Next] [New Search]